Scarica l'app Stockscreener
9.91
0.70%
-0.07
Dopo l'orario di chiusura:
9.76
-0.15
-1.51%
Cybin Inc Borsa (CYBN) Ultime notizie
What is HC Wainwright's Forecast for Cybin FY2029 Earnings? - MarketBeat
How To Trade (CYBN) - Stock Traders Daily
HC Wainwright Comments on Cybin's Q3 Earnings (NYSE:CYBN) - MarketBeat
Equities Analysts Issue Forecasts for Cybin FY2029 Earnings - MarketBeat
Cybin (OTCMKTS:CLXPF) Trading Up 1.9%Here's What Happened - MarketBeat
Wall Street Analysts Believe Cybin Inc. (CYBN) Could Rally 952.23%: Here's is How to Trade - Yahoo Finance
H.C. Wainwright maintains $190 target on Cybin Inc. shares - Investing.com
H.C. Wainwright maintains $190 target on Cybin Inc. shares By Investing.com - Investing.com Canada
HC Wainwright Reiterates "Buy" Rating for Cybin (NYSE:CYBN) - MarketBeat
Cybin (OTCMKTS:CYBN) Shares Up 1.8%Should You Buy? - MarketBeat
5-HT2 Agonist Clinical Trial Pipeline Appears Robust With 20+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight - GlobeNewswire Inc.
(CYBN) Trading Signals - Stock Traders Daily
Cybin Inc: Paradigm Changing Ambitions (NYSE:CYBN) - Seeking Alpha
Cybin enters partnership agreement to conduct phase 3 trial for depression candidate - MSN
Cybin Partners with Segal Trials for Pivotal Phase 3 Program - TipRanks
Cybin launches phase 3 trial for depression treatment - Investing.com India
Cybin launches clinical site partnerships to support PARADIGM program - TipRanks
Cybin Launches Strategic Clinical Site Partnerships to Support PARADIGM, a Multinational Pivotal Phase 3 Program Evaluating CYB003 for the Adjunctive Treatment of Major Depressive Disorder - Business Wire
Thinking about buying stock in Hanryu Holdings, Absci Corp, Spero Therapeutics, BioXcel Therapeutics, or Cybin? - Marketscreener.com
Occidental Petroleum Corp (OXY-N) QuotePress Release - The Globe and Mail
Cybin Inc. Achieves Breakthroughs in Mental Health Treatment - TipRanks
Cybin Highlights 2024 Accomplishments and Upcoming Milestones for 2025 - Financial Post
Jane Street Group LLC Has $204,000 Stake in Cybin Inc. (NYSE:CYBN) - Defense World
Cybin to Participate in the Lytham Partners 2025 Investor Healthcare Summit on January 13, 2025 - BioSpace
Cybin CEO to Present at Lytham Partners Healthcare Summit: Mental Health Innovation Spotlight - StockTitan
Cybin (OTCMKTS:CLXPF) Trading 5.4% Higher – Time to Buy? - Defense World
BUSINESS WIRE NEWS RELEASES - Wallaceburg Courier Press
Cybin (OTCMKTS:CYBN) Trading Down 2% – Here’s What Happened - Defense World
Learn to Evaluate (CYBN) using the Charts - Stock Traders Daily
Cybin (NYSE:CYBN) Stock Price Up 1%Here's Why - MarketBeat
Objective long/short (CYBN) Report - Stock Traders Daily
Cybin (FRA:R7E) Total Inventories : €0.00 Mil (As of Sep. 2024) - GuruFocus.com
Facet Life Sciences Partners with Cybin to Advance Mental Health Therapies - MSN
Cybin Reveals Promising Results in Depression Treatment - TipRanks
Cybin's Breakthrough Clinical Data Shows 100% Response Rate in Depression Treatment Study - StockTitan
Cybin Announces Poster Presentations at the 2024 American College of Neuropsychopharmacology Annual Meeting, Including CYB003 12-Month Efficacy Results - Business Wire
(CYBN) Investment Report - Stock Traders Daily
PEAK6 Investments LLC Sells 420,512 Shares of Cybin Inc. (NYSE:CYBN) - MarketBeat
Cybin Stock In Focus On MDD Treatment's 'Breakthrough’ Efficacy: Retail Turns Extremely Bullish - MSN
Cybin to Participate in Water Tower Research Fireside Chat on December 11, 2024 - Chatham-Kent This Week
Cybin to Discuss Breakthrough Treatments at Fireside Chat - TipRanks
TANG CAPITAL MANAGEMENT LLC Increases Stake in Cybin Inc - GuruFocus.com
Psychedelic Drugs Market Growth in Future Scope 2024-2031 | - openPR
Cybin (FRA:R7E) 3-Year EPS without NRI Growth Rate : 6.10% (As of Sep. 2024) - GuruFocus.com
Cybin (FRA:R7E) 50-Day SMA : €9.05 (As of Nov. 30, 2024) - GuruFocus.com
Cybin (OTCMKTS:CYBN) Stock Price Down 4.3%What's Next? - MarketBeat
FDA's Psychedelic Reckoning - Life Science Leader Magazine
Cybin (STU:R7E) Earnings Yield (Joel Greenblatt) % : -151.52% (As of Sep. 2024) - GuruFocus.com
Cybin Inc. Advances in Mental Health Treatments - TipRanks
Cybin (STU:R7E) Change In Receivables : €-1.00 Mil (TTM As of Sep. 2024) - GuruFocus.com
What is Bloom Burton's Estimate for Cybin FY2025 Earnings? - MarketBeat
3.95%
2.39%
Capitalizzazione:
|
Volume (24 ore):